| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |